(Q50480283)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686738%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686738%20AND%20SRC:MED&resulttype=core&format=json

primary biliary cholangitis

1 March 2020

main subject

osteoporosis

0 references

0 references

author

Albert Pares

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686738%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Laia Gifre

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686738%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Núria Guañabens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686738%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Anna Monegal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686738%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Dacia Cerdá

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686738%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

África Muxí

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686738%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Pilar Peris

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686738%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

English

0 references

publication date

29 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686738%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686738%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686738%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686738%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

2070-2078

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686738%20AND%20SRC:MED&resulttype=core&format=json

Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis.

1 March 2020

cites work

1 reference

Bone disease in primary biliary cirrhosis: independent indicators and rate of progression.

21 January 2018

1 reference

An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis

21 January 2018

1 reference

Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study

21 January 2018

1 reference

Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial

21 January 2018

1 reference

Continuing bisphosphonate treatment for osteoporosis--for whom and for how long?

21 January 2018

1 reference

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

21 January 2018

1 reference

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study

21 January 2018

1 reference

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

21 January 2018

1 reference

Guidelines on the management of osteoporosis associated with chronic liver disease

21 January 2018

1 reference

AGA technical review on osteoporosis in hepatic disorders.

21 January 2018

1 reference

21 January 2018

1 reference

Treatment of bone disorders in liver disease

21 January 2018

1 reference

Adherence, patient preference and dosing frequency: understanding the relationship

21 January 2018

1 reference

A systematic review of persistence and compliance with bisphosphonates for osteoporosis

21 January 2018

1 reference

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

21 January 2018

1 reference

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

21 January 2018

1 reference

Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis

21 January 2018

1 reference

25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis.

21 January 2018

1 reference

Bone disorders in chronic liver disease

21 January 2018

1 reference

Osteoporosis in Primary Biliary Cirrhosis: A Randomized Trial of the Efficacy and Feasibility of Estrogen/Progestin

21 January 2018

1 reference

Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment

21 January 2018

1 reference

7 January 2021

Sodium fluoride prevents bone loss in primary biliary cirrhosis

1 reference

7 January 2021

Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years

1 reference

7 January 2021

Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial

1 reference

7 January 2021

Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study

1 reference

7 January 2021

Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation

1 reference

7 January 2021

Effect of Monitoring Bone Turnover Markers on Persistence with Risedronate Treatment of Postmenopausal Osteoporosis

1 reference

7 January 2021

Oral bisphosphonates and upper gastrointestinal tract problems: what is the evidence?

1 reference

7 January 2021

Parenteral bisphosphonates for osteoporosis in patients with primary biliary cirrhosis

1 reference

7 January 2021

Patients with cirrhosis and ascites have false values of bone density: implications for the diagnosis of osteoporosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26466

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686738%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference